Aspect Biosystems and Novo Nordisk A/S have entered a collaboration, development, and licensing agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body, …
The post Aspect Biosystems and Novo Nordisk enter bioprinted tissue therapeutics partnership appeared first on VoxelMatters – The heart of additive manufacturing.
